American Portfolios Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

American Portfolios Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-97	Closed	-$1.75K	–	3023
2020 Q2	$1.75K	Hold	97	–	–	﹤0.01%	2589
2020 Q1	$692	Hold	97	–	–	﹤0.01%	2626
2019 Q4	$2.32K	Hold	97	–	–	﹤0.01%	2546
2019 Q3	$2.6K	Hold	97	–	–	﹤0.01%	2435
2019 Q2	$2.63K	Sell	97 -50	-34%	-$1.57K	﹤0.01%	2395
2019 Q1	$5.1K	Hold	147	–	–	﹤0.01%	2092
2018 Q4	$2.87K	Hold	147	–	–	﹤0.01%	2044
2018 Q3	$3.92K	Hold	147	–	–	﹤0.01%	2075
2018 Q2	$5.55K	Sell	147 -25	-15%	-$956	﹤0.01%	1946
2018 Q1	$5.62K	Buy	172 +125	+266%	+$5.49K	﹤0.01%	1847
2017 Q4	$2.29K	Buy	+47	New	+$2.38K	﹤0.01%	2026

American Portfolios Advisors's PTLA Position: Q3 2020 in Review

American Portfolios Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 97 shares — an estimated $1.75K sold.

American Portfolios Advisors first reported a position in PTLA in Q4 2017 and held it in 11 quarters. The position peaked at $5.62K in Q1 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

American Portfolios Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
American Portfolios Advisors sold 97 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.75K.
American Portfolios Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 11 quarters.
American Portfolios Advisors's Portola Pharmaceuticals, Inc. position peaked at $5.62K in Q1 2018.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on American Portfolios Advisors's 13F filing for Q3 2020, filed 22 Mar 2023.